- > About Us
- > CSR (Corporate Social Responsibility)
- > CSR Activities in Six Priority Areas
- > Improving Access to Healthcare
- > Research & Development
Research & Development
We prioritize the allocation of research and development resources to the field of oncology, an area in which global issues regarding access to healthcare are faced in both developed and developing countries.
2.Combating rare diseases
We tackle rare diseases and preventive medicine which are the global issues.
In order to make effective use of our resources, we will advance research and development ventures with an aim to engaging in partnerships with various public- and private-sector entities.
We have been focusing on open innovation activities and have taken many approaches for expansion of external networks for creating new drugs and securement of various innovation sources, such as collaborative research, sharing compound library and funding.
5.Scholarships for Contributing to the Advancement of Medicine and Pharmacology
We provide scholarships aimed at supporting research for contributing to the advancement of medicine and pharmacology in accordance with strict procedures.
6.Disclosure of Clinical Trials
We recognize that it is important to properly disclose clinical trials as a sponsor to a wide range of stakeholders in accordance with regulations and guidelines of each country/industry associations. Accordingly, we practice proactive information disclosure. Furthermore, it is also important to share clinical trial data to outside researchers to deepen their understanding of medicines, to disseminate scientific knowledge, which will lead the development of medical care for patients.